COMMON STOCK (Details Narrative) - shares |
9 Months Ended | |
|---|---|---|
Sep. 30, 2026 |
Dec. 31, 2025 |
|
| Subsidiary or Equity Method Investee [Line Items] | ||
| Common Stock, Shares, Issued | 1,054,689,224 | 1,054,689,224 |
| Nika BioTechnology, Inc. | ||
| Subsidiary or Equity Method Investee [Line Items] | ||
| Common Stock, Shares, Issued | 7,140,000 | |
| Business Combination, Consideration Transferred, Equity Interest, Share Issued, Number of Shares | 204,205,027 |
| X | ||||||||||
- Definition Number of shares of equity interest issued or issuable by acquirer as part of consideration transferred in business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|